

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.16029815 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.16029815 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.97531930 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.97531930 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.51074838 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.06707263 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.01010720 |
| 8 | kynurenine metabolic process (GO:0070189) | 5.98458590 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.91555613 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.91555613 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.91555613 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.70033364 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.58874446 |
| 14 | urea cycle (GO:0000050) | 5.45247587 |
| 15 | urea metabolic process (GO:0019627) | 5.45247587 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.43559430 |
| 17 | serine family amino acid catabolic process (GO:0009071) | 5.37573358 |
| 18 | cysteine metabolic process (GO:0006534) | 5.33950850 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.33031621 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.25421564 |
| 21 | lysine metabolic process (GO:0006553) | 5.16967645 |
| 22 | lysine catabolic process (GO:0006554) | 5.16967645 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.14340959 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.04345434 |
| 25 | glycine metabolic process (GO:0006544) | 5.04046327 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.03273531 |
| 27 | protein carboxylation (GO:0018214) | 5.03273531 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.00822960 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.00709658 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.00420160 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.95537246 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.94311346 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.89169107 |
| 34 | bile acid metabolic process (GO:0008206) | 4.84470989 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.78648332 |
| 36 | alpha-amino acid catabolic process (GO:1901606) | 4.68611569 |
| 37 | regulation of complement activation (GO:0030449) | 4.66324519 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.65964492 |
| 39 | serine family amino acid metabolic process (GO:0009069) | 4.58400775 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.55279793 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.51345978 |
| 42 | serine family amino acid biosynthetic process (GO:0009070) | 4.50163513 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 4.46309258 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.45540215 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.45540215 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.45540215 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.44660459 |
| 48 | establishment of integrated proviral latency (GO:0075713) | 4.38970871 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.38481100 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.38481100 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.36708891 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.36708891 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.33366712 |
| 54 | imidazole-containing compound metabolic process (GO:0052803) | 4.33173397 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 4.23431900 |
| 56 | ethanol oxidation (GO:0006069) | 4.22666459 |
| 57 | nuclear pore complex assembly (GO:0051292) | 4.22049396 |
| 58 | phospholipid efflux (GO:0033700) | 4.17892474 |
| 59 | cellular glucuronidation (GO:0052695) | 4.12992349 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.12872750 |
| 61 | chromatin remodeling at centromere (GO:0031055) | 4.10854134 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.10424191 |
| 63 | glutamate metabolic process (GO:0006536) | 4.10118199 |
| 64 | CENP-A containing nucleosome assembly (GO:0034080) | 4.08063809 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.05970308 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 4.04824429 |
| 67 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.03897594 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.03731637 |
| 69 | amine catabolic process (GO:0009310) | 4.03731637 |
| 70 | aldehyde catabolic process (GO:0046185) | 4.02395596 |
| 71 | nuclear pore organization (GO:0006999) | 3.99712706 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 3.99487465 |
| 73 | aspartate family amino acid catabolic process (GO:0009068) | 3.95988292 |
| 74 | acetyl-CoA metabolic process (GO:0006084) | 3.91934336 |
| 75 | 2-oxoglutarate metabolic process (GO:0006103) | 3.91503843 |
| 76 | DNA unwinding involved in DNA replication (GO:0006268) | 3.90940180 |
| 77 | ketone body metabolic process (GO:1902224) | 3.90137824 |
| 78 | arginine metabolic process (GO:0006525) | 3.86923988 |
| 79 | cholesterol efflux (GO:0033344) | 3.85281488 |
| 80 | organic acid catabolic process (GO:0016054) | 3.84732547 |
| 81 | carboxylic acid catabolic process (GO:0046395) | 3.84732547 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 3.82723524 |
| 83 | protein localization to kinetochore (GO:0034501) | 3.78727254 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.77457732 |
| 85 | carnitine metabolic process (GO:0009437) | 3.76933419 |
| 86 | purine nucleobase biosynthetic process (GO:0009113) | 3.76403457 |
| 87 | drug catabolic process (GO:0042737) | 3.75717965 |
| 88 | phospholipid homeostasis (GO:0055091) | 3.74297198 |
| 89 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.74255367 |
| 90 | fibrinolysis (GO:0042730) | 3.73296790 |
| 91 | fatty acid beta-oxidation (GO:0006635) | 3.72457780 |
| 92 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.70242510 |
| 93 | blood coagulation, intrinsic pathway (GO:0007597) | 3.67649630 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.67394247 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 3.65278954 |
| 96 | fatty acid oxidation (GO:0019395) | 3.64463933 |
| 97 | IMP biosynthetic process (GO:0006188) | 3.62645501 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.62415485 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.62415485 |
| 100 | DNA replication checkpoint (GO:0000076) | 3.62181569 |
| 101 | sterol homeostasis (GO:0055092) | 3.61939382 |
| 102 | DNA strand elongation (GO:0022616) | 3.60579817 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60193293 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60193293 |
| 105 | monocarboxylic acid catabolic process (GO:0072329) | 3.59480529 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.57263626 |
| 107 | cofactor catabolic process (GO:0051187) | 3.56547240 |
| 108 | lipid oxidation (GO:0034440) | 3.56369122 |
| 109 | mitotic metaphase plate congression (GO:0007080) | 3.54845448 |
| 110 | positive regulation of lipid catabolic process (GO:0050996) | 3.54488429 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.51926526 |
| 112 | DNA replication-independent nucleosome organization (GO:0034724) | 3.49937569 |
| 113 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.49937569 |
| 114 | fatty acid catabolic process (GO:0009062) | 3.49821826 |
| 115 | L-serine metabolic process (GO:0006563) | 3.49671876 |
| 116 | nucleobase biosynthetic process (GO:0046112) | 3.44527141 |
| 117 | ribosome assembly (GO:0042255) | 3.38428906 |
| 118 | heterochromatin organization (GO:0070828) | 3.38159857 |
| 119 | protein localization to chromosome, centromeric region (GO:0071459) | 3.38154472 |
| 120 | histone exchange (GO:0043486) | 3.37217018 |
| 121 | IMP metabolic process (GO:0046040) | 3.32105087 |
| 122 | establishment of viral latency (GO:0019043) | 3.26845389 |
| 123 | non-recombinational repair (GO:0000726) | 3.23876973 |
| 124 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.23876973 |
| 125 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.20727114 |
| 126 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.20727114 |
| 127 | pre-miRNA processing (GO:0031054) | 3.19958544 |
| 128 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.19748368 |
| 129 | mitotic sister chromatid segregation (GO:0000070) | 3.18901381 |
| 130 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.16151183 |
| 131 | pore complex assembly (GO:0046931) | 3.14421479 |
| 132 | metaphase plate congression (GO:0051310) | 3.13892604 |
| 133 | formation of translation preinitiation complex (GO:0001731) | 3.09850011 |
| 134 | sister chromatid segregation (GO:0000819) | 3.03853103 |
| 135 | paraxial mesoderm development (GO:0048339) | 3.02362647 |
| 136 | mitotic sister chromatid cohesion (GO:0007064) | 2.98773567 |
| 137 | DNA replication initiation (GO:0006270) | 2.97720494 |
| 138 | protein complex localization (GO:0031503) | 2.97643587 |
| 139 | mitotic nuclear envelope disassembly (GO:0007077) | 2.94311038 |
| 140 | tetrahydrofolate metabolic process (GO:0046653) | 2.85161430 |
| 141 | DNA ligation (GO:0006266) | 2.81159659 |
| 142 | mitotic chromosome condensation (GO:0007076) | 2.80059597 |
| 143 | regulation of helicase activity (GO:0051095) | 2.79615404 |
| 144 | proteasome assembly (GO:0043248) | 2.79424281 |
| 145 | spindle checkpoint (GO:0031577) | 2.79009131 |
| 146 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.76941972 |
| 147 | regulation of chromosome segregation (GO:0051983) | 2.75740378 |
| 148 | negative regulation of chromosome segregation (GO:0051985) | 2.74949903 |
| 149 | telomere maintenance via recombination (GO:0000722) | 2.73194830 |
| 150 | mitotic recombination (GO:0006312) | 2.72753805 |
| 151 | ATP-dependent chromatin remodeling (GO:0043044) | 2.71320637 |
| 152 | regulation of translational fidelity (GO:0006450) | 2.70357856 |
| 153 | mitotic spindle checkpoint (GO:0071174) | 2.70149069 |
| 154 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.70060547 |
| 155 | negative regulation of sister chromatid segregation (GO:0033046) | 2.70060547 |
| 156 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.70060547 |
| 157 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.70060547 |
| 158 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.70060547 |
| 159 | spliceosomal snRNP assembly (GO:0000387) | 2.65480870 |
| 160 | membrane disassembly (GO:0030397) | 2.64504280 |
| 161 | nuclear envelope disassembly (GO:0051081) | 2.64504280 |
| 162 | chromatin assembly or disassembly (GO:0006333) | 2.64118325 |
| 163 | DNA strand renaturation (GO:0000733) | 2.63924089 |
| 164 | regulation of centriole replication (GO:0046599) | 2.63757718 |
| 165 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.63203498 |
| 166 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.62253469 |
| 167 | kinetochore organization (GO:0051383) | 2.61788168 |
| 168 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.60521862 |
| 169 | tRNA aminoacylation for protein translation (GO:0006418) | 2.60254538 |
| 170 | regulation of mitochondrial translation (GO:0070129) | 2.59830012 |
| 171 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.59115188 |
| 172 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.59060448 |
| 173 | tRNA aminoacylation (GO:0043039) | 2.58689393 |
| 174 | amino acid activation (GO:0043038) | 2.58689393 |
| 175 | regulation of centrosome cycle (GO:0046605) | 2.57955869 |
| 176 | regulation of sister chromatid cohesion (GO:0007063) | 2.57814026 |
| 177 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.57464178 |
| 178 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.57464178 |
| 179 | positive regulation of chromosome segregation (GO:0051984) | 2.56305378 |
| 180 | cellular protein complex localization (GO:0034629) | 2.55046083 |
| 181 | DNA damage response, detection of DNA damage (GO:0042769) | 2.54272818 |
| 182 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.50844491 |
| 183 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.50844491 |
| 184 | mitotic spindle assembly checkpoint (GO:0007094) | 2.50349222 |
| 185 | establishment of chromosome localization (GO:0051303) | 2.49479055 |
| 186 | spindle assembly checkpoint (GO:0071173) | 2.46574749 |
| 187 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.46341834 |
| 188 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.46341834 |
| 189 | regulation of sister chromatid segregation (GO:0033045) | 2.46341834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.54570053 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.63387660 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.37268527 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.74911654 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.01545708 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.85539075 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.62908144 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.91825148 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.70976822 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.55453426 |
| 11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.45719923 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.69106476 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.62141275 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.51171592 |
| 15 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.50882661 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.49875677 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.44679476 |
| 18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.38055847 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29462483 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18863461 |
| 21 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.12528069 |
| 22 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.12256579 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.07050729 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.05753830 |
| 25 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02423662 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9655670 |
| 27 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.97699669 |
| 28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.91712033 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.89136222 |
| 30 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88203896 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.87006749 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.84909419 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.84274153 |
| 34 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.83355738 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.79721402 |
| 36 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.78568327 |
| 37 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.72126290 |
| 38 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.68928484 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.61382876 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60190738 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59842153 |
| 42 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.57241198 |
| 43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.56993556 |
| 44 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.56034487 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.53795175 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.52353211 |
| 47 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.49980714 |
| 48 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.49821007 |
| 49 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.43664143 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40885912 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39779474 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.36700950 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34753579 |
| 54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33314573 |
| 55 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30990142 |
| 56 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26925549 |
| 57 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25090160 |
| 58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23356311 |
| 59 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.22601476 |
| 60 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22432720 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21733654 |
| 62 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.21188808 |
| 63 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19473717 |
| 64 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.19416578 |
| 65 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.19003162 |
| 66 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16388006 |
| 67 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15587387 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14342173 |
| 69 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.13915572 |
| 70 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.13453935 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13379341 |
| 72 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.11570738 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10482456 |
| 74 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.10013599 |
| 75 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09215050 |
| 76 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07787577 |
| 77 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06524746 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05630636 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02854644 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.00517302 |
| 81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00261498 |
| 82 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99839546 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98594966 |
| 84 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.96274165 |
| 85 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.95482648 |
| 86 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.93060471 |
| 87 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.91003533 |
| 88 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90809666 |
| 89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90739714 |
| 90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.89668171 |
| 91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89105938 |
| 92 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.88166514 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86995446 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85554308 |
| 95 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83310075 |
| 96 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.83203884 |
| 97 | EWS_26573619_Chip-Seq_HEK293_Human | 0.82375230 |
| 98 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81760408 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80651210 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79262532 |
| 101 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.79089620 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79072249 |
| 103 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.79030889 |
| 104 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.78356579 |
| 105 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.78142978 |
| 106 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.78142625 |
| 107 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.75834474 |
| 108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75663822 |
| 109 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74557592 |
| 110 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.74302151 |
| 111 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.74293543 |
| 112 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74083176 |
| 113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.73964199 |
| 114 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.72782183 |
| 115 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.71836102 |
| 116 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70115300 |
| 117 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.68325912 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.66540470 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65777539 |
| 120 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.64283735 |
| 121 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.64190623 |
| 122 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63904948 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63415940 |
| 124 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.62029718 |
| 125 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.60984472 |
| 126 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.60118258 |
| 127 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.59649925 |
| 128 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.59515170 |
| 129 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.58584854 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57695208 |
| 131 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.57572806 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57509639 |
| 133 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.57337770 |
| 134 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.56950492 |
| 135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56315367 |
| 136 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.55406723 |
| 137 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.53134281 |
| 138 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.52299160 |
| 139 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.50738982 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.50646397 |
| 141 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.50589673 |
| 142 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.50408736 |
| 143 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.50153327 |
| 144 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.50000891 |
| 145 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.50000891 |
| 146 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.50000891 |
| 147 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.48317059 |
| 148 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48293421 |
| 149 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.48230068 |
| 150 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.48029564 |
| 151 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.47877389 |
| 152 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47463643 |
| 153 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.46528577 |
| 154 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46521091 |
| 155 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.46031391 |
| 156 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.45455037 |
| 157 | ATF3_27146783_Chip-Seq_COLON_Human | 0.45017124 |
| 158 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.44314660 |
| 159 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.44256859 |
| 160 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.43759997 |
| 161 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.43271076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.82704050 |
| 2 | MP0005360_urolithiasis | 7.29039965 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.24663777 |
| 4 | MP0005365_abnormal_bile_salt | 5.82364070 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.93938973 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.75836708 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.73899218 |
| 8 | MP0003252_abnormal_bile_duct | 3.68856973 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 3.57945015 |
| 10 | MP0010094_abnormal_chromosome_stability | 3.36805274 |
| 11 | MP0009840_abnormal_foam_cell | 3.28764869 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.25683464 |
| 13 | MP0008057_abnormal_DNA_replication | 3.14138781 |
| 14 | MP0003111_abnormal_nucleus_morphology | 3.10969877 |
| 15 | MP0005083_abnormal_biliary_tract | 2.94796419 |
| 16 | MP0003941_abnormal_skin_development | 2.86587103 |
| 17 | MP0005332_abnormal_amino_acid | 2.80050138 |
| 18 | MP0003195_calcinosis | 2.66878992 |
| 19 | MP0008932_abnormal_embryonic_tissue | 2.65674146 |
| 20 | MP0008058_abnormal_DNA_repair | 2.57685712 |
| 21 | MP0003077_abnormal_cell_cycle | 2.52897965 |
| 22 | MP0003890_abnormal_embryonic-extraembry | 2.39859781 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.38768266 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.16075149 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.09305823 |
| 26 | * MP0000609_abnormal_liver_physiology | 2.07471682 |
| 27 | MP0001730_embryonic_growth_arrest | 2.01003616 |
| 28 | MP0008007_abnormal_cellular_replicative | 1.97606005 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.95191859 |
| 30 | MP0001293_anophthalmia | 1.92390539 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.90417205 |
| 32 | * MP0002118_abnormal_lipid_homeostasis | 1.89633345 |
| 33 | MP0010030_abnormal_orbit_morphology | 1.87084199 |
| 34 | MP0003937_abnormal_limbs/digits/tail_de | 1.74391132 |
| 35 | MP0002938_white_spotting | 1.68680847 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.67842550 |
| 37 | MP0003123_paternal_imprinting | 1.65546775 |
| 38 | MP0002697_abnormal_eye_size | 1.63902674 |
| 39 | MP0003868_abnormal_feces_composition | 1.62313284 |
| 40 | MP0003136_yellow_coat_color | 1.61651019 |
| 41 | MP0009697_abnormal_copulation | 1.61259841 |
| 42 | MP0003186_abnormal_redox_activity | 1.60283625 |
| 43 | MP0001672_abnormal_embryogenesis/_devel | 1.57856928 |
| 44 | MP0005380_embryogenesis_phenotype | 1.57856928 |
| 45 | MP0001697_abnormal_embryo_size | 1.55118318 |
| 46 | MP0000537_abnormal_urethra_morphology | 1.54120891 |
| 47 | MP0005451_abnormal_body_composition | 1.53267193 |
| 48 | MP0000350_abnormal_cell_proliferation | 1.47300411 |
| 49 | MP0002084_abnormal_developmental_patter | 1.47143382 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.46902100 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.46833912 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45925078 |
| 53 | * MP0001764_abnormal_homeostasis | 1.43236403 |
| 54 | MP0003122_maternal_imprinting | 1.42510019 |
| 55 | MP0003984_embryonic_growth_retardation | 1.40069504 |
| 56 | MP0002085_abnormal_embryonic_tissue | 1.39963494 |
| 57 | MP0002088_abnormal_embryonic_growth/wei | 1.35887514 |
| 58 | MP0000598_abnormal_liver_morphology | 1.27618445 |
| 59 | * MP0009643_abnormal_urine_homeostasis | 1.27574720 |
| 60 | MP0005187_abnormal_penis_morphology | 1.26949698 |
| 61 | MP0003119_abnormal_digestive_system | 1.26300269 |
| 62 | MP0002080_prenatal_lethality | 1.24516562 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.22462955 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.21190732 |
| 65 | MP0003315_abnormal_perineum_morphology | 1.20516907 |
| 66 | MP0002233_abnormal_nose_morphology | 1.19311712 |
| 67 | MP0003011_delayed_dark_adaptation | 1.19165712 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.18765374 |
| 69 | MP0004272_abnormal_basement_membrane | 1.16724575 |
| 70 | MP0001286_abnormal_eye_development | 1.13173076 |
| 71 | MP0000566_synostosis | 1.11501339 |
| 72 | MP0003121_genomic_imprinting | 1.10492932 |
| 73 | MP0002092_abnormal_eye_morphology | 1.08255456 |
| 74 | MP0009703_decreased_birth_body | 1.08144559 |
| 75 | MP0002086_abnormal_extraembryonic_tissu | 1.08038333 |
| 76 | MP0002111_abnormal_tail_morphology | 1.07726266 |
| 77 | MP0004197_abnormal_fetal_growth/weight/ | 1.07044962 |
| 78 | MP0002254_reproductive_system_inflammat | 1.06883936 |
| 79 | MP0000647_abnormal_sebaceous_gland | 1.06267087 |
| 80 | MP0010307_abnormal_tumor_latency | 1.06041118 |
| 81 | MP0005647_abnormal_sex_gland | 1.05824448 |
| 82 | MP0009763_increased_sensitivity_to | 1.05523758 |
| 83 | MP0002090_abnormal_vision | 1.05254217 |
| 84 | MP0000372_irregular_coat_pigmentation | 1.05022073 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 1.00939132 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.97905728 |
| 87 | MP0008877_abnormal_DNA_methylation | 0.96732578 |
| 88 | MP0005266_abnormal_metabolism | 0.95706198 |
| 89 | MP0005408_hypopigmentation | 0.92122362 |
| 90 | MP0003786_premature_aging | 0.91650744 |
| 91 | MP0005670_abnormal_white_adipose | 0.88751853 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 0.85015909 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.84632890 |
| 94 | MP0009764_decreased_sensitivity_to | 0.83520151 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.83516324 |
| 96 | MP0009053_abnormal_anal_canal | 0.82556128 |
| 97 | MP0008469_abnormal_protein_level | 0.82285604 |
| 98 | * MP0005376_homeostasis/metabolism_phenot | 0.81225262 |
| 99 | MP0008789_abnormal_olfactory_epithelium | 0.79871751 |
| 100 | MP0001324_abnormal_eye_pigmentation | 0.79673248 |
| 101 | MP0000313_abnormal_cell_death | 0.78613464 |
| 102 | * MP0009642_abnormal_blood_homeostasis | 0.78545594 |
| 103 | MP0004130_abnormal_muscle_cell | 0.78117896 |
| 104 | MP0005499_abnormal_olfactory_system | 0.77559559 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.77559559 |
| 106 | MP0003718_maternal_effect | 0.76345857 |
| 107 | MP0005391_vision/eye_phenotype | 0.75793798 |
| 108 | MP0000428_abnormal_craniofacial_morphol | 0.75704138 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.75431470 |
| 110 | MP0005197_abnormal_uvea_morphology | 0.75071000 |
| 111 | MP0004233_abnormal_muscle_weight | 0.74672250 |
| 112 | MP0000358_abnormal_cell_content/ | 0.74448860 |
| 113 | MP0001529_abnormal_vocalization | 0.73977437 |
| 114 | MP0002751_abnormal_autonomic_nervous | 0.73808998 |
| 115 | MP0000604_amyloidosis | 0.72524138 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.72223677 |
| 117 | MP0002210_abnormal_sex_determination | 0.69693238 |
| 118 | MP0005330_cardiomyopathy | 0.67799440 |
| 119 | MP0005257_abnormal_intraocular_pressure | 0.66985293 |
| 120 | MP0003943_abnormal_hepatobiliary_system | 0.66735133 |
| 121 | MP0003861_abnormal_nervous_system | 0.66594787 |
| 122 | MP0010678_abnormal_skin_adnexa | 0.66059497 |
| 123 | MP0001145_abnormal_male_reproductive | 0.65907981 |
| 124 | MP0001929_abnormal_gametogenesis | 0.65081453 |
| 125 | MP0003935_abnormal_craniofacial_develop | 0.64510639 |
| 126 | MP0000432_abnormal_head_morphology | 0.63872064 |
| 127 | MP0002163_abnormal_gland_morphology | 0.63837174 |
| 128 | * MP0002078_abnormal_glucose_homeostasis | 0.63760022 |
| 129 | MP0002971_abnormal_brown_adipose | 0.62694808 |
| 130 | MP0001756_abnormal_urination | 0.60936225 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.59675085 |
| 132 | MP0005220_abnormal_exocrine_pancreas | 0.59637870 |
| 133 | MP0002269_muscular_atrophy | 0.58650868 |
| 134 | MP0005084_abnormal_gallbladder_morpholo | 0.58231235 |
| 135 | MP0001661_extended_life_span | 0.58023219 |
| 136 | MP0005395_other_phenotype | 0.56686068 |
| 137 | MP0005334_abnormal_fat_pad | 0.53648143 |
| 138 | MP0003646_muscle_fatigue | 0.53031952 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.52821816 |
| 140 | MP0009672_abnormal_birth_weight | 0.47915226 |
| 141 | MP0008873_increased_physiological_sensi | 0.47555602 |
| 142 | MP0003221_abnormal_cardiomyocyte_apopto | 0.47449043 |
| 143 | MP0004084_abnormal_cardiac_muscle | 0.44262044 |
| 144 | MP0001853_heart_inflammation | 0.44241734 |
| 145 | MP0005023_abnormal_wound_healing | 0.43096593 |
| 146 | MP0000639_abnormal_adrenal_gland | 0.41923621 |
| 147 | MP0005464_abnormal_platelet_physiology | 0.39844258 |
| 148 | MP0002796_impaired_skin_barrier | 0.39624946 |
| 149 | MP0005535_abnormal_body_temperature | 0.38746329 |
| 150 | MP0004264_abnormal_extraembryonic_tissu | 0.38244021 |
| 151 | MP0004782_abnormal_surfactant_physiolog | 0.38069320 |
| 152 | MP0010630_abnormal_cardiac_muscle | 0.37375518 |
| 153 | MP0001544_abnormal_cardiovascular_syste | 0.37006664 |
| 154 | MP0005385_cardiovascular_system_phenoty | 0.37006664 |
| 155 | MP0003638_abnormal_response/metabolism_ | 0.35608837 |
| 156 | MP0005248_abnormal_Harderian_gland | 0.34966438 |
| 157 | MP0001915_intracranial_hemorrhage | 0.34545932 |
| 158 | MP0003690_abnormal_glial_cell | 0.34537222 |
| 159 | MP0005448_abnormal_energy_balance | 0.33046288 |
| 160 | MP0002928_abnormal_bile_duct | 0.32776859 |
| 161 | MP0002970_abnormal_white_adipose | 0.32634299 |
| 162 | MP0008775_abnormal_heart_ventricle | 0.32412490 |
| 163 | MP0006138_congestive_heart_failure | 0.32114902 |
| 164 | MP0009115_abnormal_fat_cell | 0.29697805 |
| 165 | MP0002332_abnormal_exercise_endurance | 0.29393544 |
| 166 | MP0004036_abnormal_muscle_relaxation | 0.28656705 |
| 167 | MP0003453_abnormal_keratinocyte_physiol | 0.28371839 |
| 168 | MP0003436_decreased_susceptibility_to | 0.28310806 |
| 169 | MP0002876_abnormal_thyroid_physiology | 0.28295613 |
| 170 | MP0000579_abnormal_nail_morphology | 0.28288553 |
| 171 | MP0000249_abnormal_blood_vessel | 0.27745284 |
| 172 | MP0001243_abnormal_dermal_layer | 0.27355042 |
| 173 | MP0004185_abnormal_adipocyte_glucose | 0.27137895 |
| 174 | MP0000230_abnormal_systemic_arterial | 0.26331077 |
| 175 | MP0002135_abnormal_kidney_morphology | 0.26047429 |
| 176 | MP0003567_abnormal_fetal_cardiomyocyte | 0.25838646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.88601304 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.83510101 |
| 3 | * Intrahepatic cholestasis (HP:0001406) | 6.79768774 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.61035400 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.27977133 |
| 6 | Xanthomatosis (HP:0000991) | 6.06276437 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.92892277 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.13594562 |
| 9 | * Hyperammonemia (HP:0001987) | 4.80041715 |
| 10 | Complement deficiency (HP:0004431) | 4.77866657 |
| 11 | Hyperglycinemia (HP:0002154) | 4.66466361 |
| 12 | Hyperglycinuria (HP:0003108) | 4.44771978 |
| 13 | Ketosis (HP:0001946) | 4.44144949 |
| 14 | * Hypolipoproteinemia (HP:0010981) | 4.39115476 |
| 15 | Epidermoid cyst (HP:0200040) | 4.37818636 |
| 16 | Joint hemorrhage (HP:0005261) | 4.35602707 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.34232876 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.34232876 |
| 19 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.28116169 |
| 20 | Hypoglycemic coma (HP:0001325) | 4.26167750 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.18078286 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.04437126 |
| 23 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.01750274 |
| 24 | * Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.99850137 |
| 25 | Fat malabsorption (HP:0002630) | 3.95955324 |
| 26 | * Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.91956162 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.82400923 |
| 28 | * Abnormality of methionine metabolism (HP:0010901) | 3.82360865 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.57101144 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.55617854 |
| 31 | Abnormality of complement system (HP:0005339) | 3.53205956 |
| 32 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.43056672 |
| 33 | * Hypoalphalipoproteinemia (HP:0003233) | 3.42508720 |
| 34 | Abnormality of serum amino acid levels (HP:0003112) | 3.41270258 |
| 35 | Ketoacidosis (HP:0001993) | 3.33031329 |
| 36 | Chromsome breakage (HP:0040012) | 3.32909562 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.24483595 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.24391249 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.16050374 |
| 40 | Dicarboxylic aciduria (HP:0003215) | 3.09528227 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.09528227 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 3.09137897 |
| 43 | Abnormality of glycolysis (HP:0004366) | 3.07226176 |
| 44 | Increased serum pyruvate (HP:0003542) | 3.03039714 |
| 45 | * Hyperbilirubinemia (HP:0002904) | 3.02363015 |
| 46 | * Hypercholesterolemia (HP:0003124) | 3.00237977 |
| 47 | Steatorrhea (HP:0002570) | 2.99741510 |
| 48 | Metabolic acidosis (HP:0001942) | 2.95378572 |
| 49 | Lethargy (HP:0001254) | 2.93223138 |
| 50 | Colon cancer (HP:0003003) | 2.82056117 |
| 51 | Spastic diplegia (HP:0001264) | 2.81447781 |
| 52 | Skin nodule (HP:0200036) | 2.80290242 |
| 53 | Cortical dysplasia (HP:0002539) | 2.76319748 |
| 54 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.72579062 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.72528789 |
| 56 | Myocardial infarction (HP:0001658) | 2.68576631 |
| 57 | Spontaneous abortion (HP:0005268) | 2.64127349 |
| 58 | Gout (HP:0001997) | 2.62474107 |
| 59 | Embryonal renal neoplasm (HP:0011794) | 2.59604242 |
| 60 | * Cerebral edema (HP:0002181) | 2.58571588 |
| 61 | Meckel diverticulum (HP:0002245) | 2.57960561 |
| 62 | Abnormal lung lobation (HP:0002101) | 2.57355555 |
| 63 | * Hepatocellular carcinoma (HP:0001402) | 2.56049027 |
| 64 | Increased nuchal translucency (HP:0010880) | 2.50544668 |
| 65 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.48584263 |
| 66 | Vascular calcification (HP:0004934) | 2.47982730 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.45215544 |
| 68 | Cholelithiasis (HP:0001081) | 2.45187534 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.43512914 |
| 70 | Abnormality of the ileum (HP:0001549) | 2.41515160 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.38928679 |
| 72 | Reduced antithrombin III activity (HP:0001976) | 2.37387774 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.36645878 |
| 74 | Malnutrition (HP:0004395) | 2.36559409 |
| 75 | Esophageal varix (HP:0002040) | 2.35636742 |
| 76 | Rhabdomyosarcoma (HP:0002859) | 2.33402355 |
| 77 | Multiple enchondromatosis (HP:0005701) | 2.32421312 |
| 78 | Acanthocytosis (HP:0001927) | 2.30070987 |
| 79 | Irritability (HP:0000737) | 2.29872058 |
| 80 | Hepatoblastoma (HP:0002884) | 2.29309155 |
| 81 | Vomiting (HP:0002013) | 2.29207963 |
| 82 | Abnormality of chromosome stability (HP:0003220) | 2.28391586 |
| 83 | Neonatal onset (HP:0003623) | 2.27223926 |
| 84 | Vaginal fistula (HP:0004320) | 2.22905827 |
| 85 | Acute encephalopathy (HP:0006846) | 2.21055719 |
| 86 | Proximal tubulopathy (HP:0000114) | 2.20813268 |
| 87 | Birth length less than 3rd percentile (HP:0003561) | 2.20468978 |
| 88 | Bifid tongue (HP:0010297) | 2.20216710 |
| 89 | Reticulocytopenia (HP:0001896) | 2.19056366 |
| 90 | Absent radius (HP:0003974) | 2.17882118 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.17329927 |
| 92 | Cholecystitis (HP:0001082) | 2.17329927 |
| 93 | Cardiovascular calcification (HP:0011915) | 2.17254018 |
| 94 | Nausea (HP:0002018) | 2.16766014 |
| 95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16208442 |
| 96 | Abnormality of the labia minora (HP:0012880) | 2.16124770 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 2.14889825 |
| 98 | Late onset (HP:0003584) | 2.13858699 |
| 99 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.08353514 |
| 100 | Abnormality of the preputium (HP:0100587) | 2.07496863 |
| 101 | Horseshoe kidney (HP:0000085) | 2.07247594 |
| 102 | Medulloblastoma (HP:0002885) | 2.06915631 |
| 103 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.06563725 |
| 104 | Renal cortical cysts (HP:0000803) | 2.06408594 |
| 105 | Thrombophlebitis (HP:0004418) | 2.06285263 |
| 106 | Abnormality of the anterior horn cell (HP:0006802) | 2.05466995 |
| 107 | Degeneration of anterior horn cells (HP:0002398) | 2.05466995 |
| 108 | Glomerulonephritis (HP:0000099) | 2.05162948 |
| 109 | Volvulus (HP:0002580) | 2.05010616 |
| 110 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03632316 |
| 111 | Enlarged kidneys (HP:0000105) | 2.02917208 |
| 112 | Megaloblastic anemia (HP:0001889) | 1.98625522 |
| 113 | Poikilocytosis (HP:0004447) | 1.96681341 |
| 114 | Abnormality of iron homeostasis (HP:0011031) | 1.96547182 |
| 115 | Absent forearm bone (HP:0003953) | 1.96478428 |
| 116 | Aplasia involving forearm bones (HP:0009822) | 1.96478428 |
| 117 | Facial cleft (HP:0002006) | 1.95939726 |
| 118 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95907563 |
| 119 | Gingival bleeding (HP:0000225) | 1.95328882 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 1.94490786 |
| 121 | Brushfield spots (HP:0001088) | 1.94233927 |
| 122 | Hydroxyprolinuria (HP:0003080) | 1.93823820 |
| 123 | Abnormality of proline metabolism (HP:0010907) | 1.93823820 |
| 124 | Rectal fistula (HP:0100590) | 1.93589673 |
| 125 | Rectovaginal fistula (HP:0000143) | 1.93589673 |
| 126 | Ependymoma (HP:0002888) | 1.93353929 |
| 127 | Glycosuria (HP:0003076) | 1.92519695 |
| 128 | Abnormality of urine glucose concentration (HP:0011016) | 1.92519695 |
| 129 | Symptomatic seizures (HP:0011145) | 1.92407287 |
| 130 | Opisthotonus (HP:0002179) | 1.92394932 |
| 131 | Abnormality of the duodenum (HP:0002246) | 1.91495802 |
| 132 | Abnormality of the gallbladder (HP:0005264) | 1.91452648 |
| 133 | Increased purine levels (HP:0004368) | 1.91386202 |
| 134 | Hyperuricemia (HP:0002149) | 1.91386202 |
| 135 | Myoglobinuria (HP:0002913) | 1.90205587 |
| 136 | Rickets (HP:0002748) | 1.87881880 |
| 137 | * Pancreatitis (HP:0001733) | 1.87821639 |
| 138 | Bifid scrotum (HP:0000048) | 1.86453678 |
| 139 | Menorrhagia (HP:0000132) | 1.85911745 |
| 140 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85636288 |
| 141 | Mitral stenosis (HP:0001718) | 1.84124716 |
| 142 | Triphalangeal thumb (HP:0001199) | 1.83629664 |
| 143 | Type I transferrin isoform profile (HP:0003642) | 1.82955992 |
| 144 | Amyloidosis (HP:0011034) | 1.81193865 |
| 145 | Septo-optic dysplasia (HP:0100842) | 1.80024647 |
| 146 | Hyperglycemia (HP:0003074) | 1.79954638 |
| 147 | Proximal placement of thumb (HP:0009623) | 1.79543778 |
| 148 | Microvesicular hepatic steatosis (HP:0001414) | 1.78742565 |
| 149 | Increased hepatocellular lipid droplets (HP:0006565) | 1.74870762 |
| 150 | Duodenal stenosis (HP:0100867) | 1.73590948 |
| 151 | Small intestinal stenosis (HP:0012848) | 1.73590948 |
| 152 | Deviation of the thumb (HP:0009603) | 1.72461562 |
| 153 | Anal stenosis (HP:0002025) | 1.72039615 |
| 154 | Esophageal atresia (HP:0002032) | 1.71697514 |
| 155 | Intestinal atresia (HP:0011100) | 1.70140193 |
| 156 | Acute necrotizing encephalopathy (HP:0006965) | 1.64795619 |
| 157 | Overlapping toe (HP:0001845) | 1.64074753 |
| 158 | Anophthalmia (HP:0000528) | 1.63897904 |
| 159 | Gonadotropin excess (HP:0000837) | 1.63773884 |
| 160 | Homocystinuria (HP:0002156) | 1.63391398 |
| 161 | Abnormality of homocysteine metabolism (HP:0010919) | 1.63391398 |
| 162 | Stenosis of the external auditory canal (HP:0000402) | 1.62767139 |
| 163 | Lipid accumulation in hepatocytes (HP:0006561) | 1.62288007 |
| 164 | Hemivertebrae (HP:0002937) | 1.61461944 |
| 165 | Macrocytic anemia (HP:0001972) | 1.60919402 |
| 166 | Embryonal neoplasm (HP:0002898) | 1.59764108 |
| 167 | Ectopic kidney (HP:0000086) | 1.59151552 |
| 168 | Glioma (HP:0009733) | 1.56835792 |
| 169 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.56280351 |
| 170 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.56280351 |
| 171 | Choanal atresia (HP:0000453) | 1.56187811 |
| 172 | Hyperalaninemia (HP:0003348) | 1.54466881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.20197247 |
| 2 | BUB1 | 3.58629798 |
| 3 | SRPK1 | 3.39278171 |
| 4 | FGFR4 | 3.36852446 |
| 5 | PKN2 | 3.35565114 |
| 6 | SIK1 | 3.26690497 |
| 7 | ERN1 | 3.12770814 |
| 8 | TSSK6 | 2.87891520 |
| 9 | FLT3 | 2.65148273 |
| 10 | ERBB4 | 2.61026859 |
| 11 | VRK2 | 2.48288958 |
| 12 | MKNK1 | 2.43233480 |
| 13 | TAF1 | 2.40778661 |
| 14 | PLK3 | 2.31580760 |
| 15 | PLK4 | 2.27164718 |
| 16 | NEK1 | 2.14958689 |
| 17 | EIF2AK3 | 2.08570824 |
| 18 | TRIM28 | 1.97257487 |
| 19 | MKNK2 | 1.95126407 |
| 20 | STK38L | 1.94410576 |
| 21 | TRIB3 | 1.83743018 |
| 22 | MST1R | 1.75450781 |
| 23 | LATS1 | 1.74275710 |
| 24 | TAOK3 | 1.72592509 |
| 25 | MAPK11 | 1.67577023 |
| 26 | MST4 | 1.66264914 |
| 27 | INSRR | 1.64284768 |
| 28 | MAP2K3 | 1.46693833 |
| 29 | PDK3 | 1.45786169 |
| 30 | PDK4 | 1.45786169 |
| 31 | MAP3K9 | 1.45375314 |
| 32 | WEE1 | 1.41413078 |
| 33 | KDR | 1.40471036 |
| 34 | NEK9 | 1.36679348 |
| 35 | STK16 | 1.36160237 |
| 36 | TYK2 | 1.32426200 |
| 37 | TNIK | 1.29145118 |
| 38 | ABL2 | 1.28848538 |
| 39 | MAP3K10 | 1.27630367 |
| 40 | BCR | 1.26623151 |
| 41 | CHEK2 | 1.26320070 |
| 42 | PAK4 | 1.25909623 |
| 43 | EPHA2 | 1.23644522 |
| 44 | BRSK1 | 1.23216588 |
| 45 | MAP3K3 | 1.22175162 |
| 46 | VRK1 | 1.20958980 |
| 47 | PTK6 | 1.20080801 |
| 48 | PINK1 | 1.19413863 |
| 49 | MET | 1.19023142 |
| 50 | EIF2AK1 | 1.17683594 |
| 51 | TIE1 | 1.16817164 |
| 52 | CDK4 | 1.15625006 |
| 53 | ATR | 1.15532713 |
| 54 | TTN | 1.15447278 |
| 55 | MAP2K4 | 1.11492812 |
| 56 | PIK3CG | 1.10695309 |
| 57 | TTK | 1.09539176 |
| 58 | MAP3K11 | 1.04497370 |
| 59 | CSNK1G1 | 1.03285527 |
| 60 | CDK6 | 0.99123145 |
| 61 | SMG1 | 0.97230317 |
| 62 | STK4 | 0.95632956 |
| 63 | EIF2AK2 | 0.93952597 |
| 64 | PRKAA2 | 0.93628860 |
| 65 | CHEK1 | 0.93541260 |
| 66 | NUAK1 | 0.92532107 |
| 67 | SCYL2 | 0.92090965 |
| 68 | PASK | 0.91910745 |
| 69 | PNCK | 0.90730039 |
| 70 | FGFR1 | 0.90599045 |
| 71 | DYRK3 | 0.90278324 |
| 72 | NME1 | 0.89417128 |
| 73 | ACVR1B | 0.88866147 |
| 74 | JAK2 | 0.86985106 |
| 75 | ATM | 0.86739869 |
| 76 | ALK | 0.85562704 |
| 77 | MAP3K7 | 0.83704919 |
| 78 | WNK3 | 0.83614882 |
| 79 | NME2 | 0.82597958 |
| 80 | PDK2 | 0.81910755 |
| 81 | CSNK1G3 | 0.79626380 |
| 82 | RIPK1 | 0.75806909 |
| 83 | BRD4 | 0.75336375 |
| 84 | TGFBR1 | 0.75008930 |
| 85 | BMPR1B | 0.74590555 |
| 86 | GRK6 | 0.71440567 |
| 87 | MAP3K5 | 0.71427984 |
| 88 | STK3 | 0.71117625 |
| 89 | MAP3K8 | 0.70086288 |
| 90 | ERBB2 | 0.69932925 |
| 91 | RPS6KA4 | 0.69374244 |
| 92 | AURKA | 0.69232313 |
| 93 | PBK | 0.68944748 |
| 94 | FRK | 0.68749323 |
| 95 | CSNK1E | 0.67175218 |
| 96 | MAPK4 | 0.66310936 |
| 97 | TBK1 | 0.65676238 |
| 98 | MTOR | 0.64844084 |
| 99 | PRKAA1 | 0.64506095 |
| 100 | CASK | 0.63981096 |
| 101 | OBSCN | 0.63219402 |
| 102 | CSNK1A1L | 0.63000224 |
| 103 | MYLK | 0.62978077 |
| 104 | CSNK1G2 | 0.62226802 |
| 105 | PLK2 | 0.61277840 |
| 106 | TGFBR2 | 0.61077028 |
| 107 | TAOK2 | 0.60815248 |
| 108 | RPS6KB2 | 0.60501346 |
| 109 | MAP3K14 | 0.59280573 |
| 110 | CDK1 | 0.58129833 |
| 111 | IRAK3 | 0.57374796 |
| 112 | GSK3A | 0.56858500 |
| 113 | STK10 | 0.55850761 |
| 114 | MAP2K6 | 0.55676014 |
| 115 | CDK2 | 0.53991511 |
| 116 | PRKACG | 0.53563716 |
| 117 | BRAF | 0.53198766 |
| 118 | FGFR2 | 0.52860243 |
| 119 | CDK7 | 0.50329057 |
| 120 | CSF1R | 0.49953030 |
| 121 | LATS2 | 0.49007302 |
| 122 | DYRK1B | 0.48623951 |
| 123 | AKT3 | 0.47815705 |
| 124 | ICK | 0.47209226 |
| 125 | ERBB3 | 0.45899667 |
| 126 | CDK12 | 0.44601143 |
| 127 | MAPK12 | 0.44183527 |
| 128 | PIM1 | 0.44133753 |
| 129 | FER | 0.43299056 |
| 130 | CSK | 0.43060528 |
| 131 | CAMK1G | 0.42291710 |
| 132 | CDC7 | 0.42154904 |
| 133 | PRKDC | 0.41154041 |
| 134 | PLK1 | 0.39620942 |
| 135 | BRSK2 | 0.39232149 |
| 136 | AURKB | 0.39003879 |
| 137 | AKT2 | 0.38222928 |
| 138 | CDK9 | 0.37633008 |
| 139 | JAK1 | 0.37365025 |
| 140 | YES1 | 0.36463426 |
| 141 | MAPKAPK3 | 0.36248778 |
| 142 | DAPK1 | 0.36123479 |
| 143 | DYRK2 | 0.36023515 |
| 144 | EPHB1 | 0.34958749 |
| 145 | MAP3K6 | 0.34643668 |
| 146 | MAPK7 | 0.34170280 |
| 147 | PRKCZ | 0.33801148 |
| 148 | CAMK1D | 0.32992959 |
| 149 | STK24 | 0.32319604 |
| 150 | CAMK2G | 0.32051349 |
| 151 | NEK2 | 0.31593179 |
| 152 | PIK3CA | 0.30872835 |
| 153 | LRRK2 | 0.30742005 |
| 154 | PTK2 | 0.30663484 |
| 155 | ZAK | 0.28660512 |
| 156 | CDK8 | 0.27843241 |
| 157 | CSNK2A2 | 0.26965519 |
| 158 | EGFR | 0.25632871 |
| 159 | CSNK2A1 | 0.25530531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.14229098 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.53056506 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.34449940 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21616880 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95257358 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78481533 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64564519 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61261209 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57490630 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54385026 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48631952 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45728433 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.23447889 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21159247 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.16493737 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12789878 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.08882946 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.04689042 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95513567 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88351084 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.81644086 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80714742 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78701991 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78604492 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.78540010 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77102417 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76959521 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73497999 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73280727 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72255801 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69934564 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.69744002 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68689748 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.60913946 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.59663024 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59503538 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53875199 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52554782 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51769861 |
| 40 | RNA polymerase_Homo sapiens_hsa03020 | 1.50802699 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.50800395 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50586209 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50305275 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.49362234 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48691345 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48355244 |
| 47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.44884297 |
| 48 | Ribosome_Homo sapiens_hsa03010 | 1.43052767 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36721126 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.32437350 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32076412 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31400982 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29993863 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.29155520 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25248464 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21893300 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18486837 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14611862 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13649851 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10307078 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10050527 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 1.03632487 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02038770 |
| 64 | RNA degradation_Homo sapiens_hsa03018 | 1.01289509 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99915342 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98194676 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.95797776 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.93709108 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93107401 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92405973 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90803856 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85299991 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82331287 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76327322 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74608330 |
| 76 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73219304 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72794959 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.71719428 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65354960 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63348438 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57172999 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55003067 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54773918 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54387881 |
| 85 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.52917505 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52544466 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.47177138 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46252320 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45198209 |
| 90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.42200316 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41239733 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40782472 |
| 93 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36500776 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34325789 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.33682485 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24396759 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.21526800 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20880807 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18159293 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.17819504 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16845291 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.14023018 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13084939 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.09285670 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08365159 |
| 106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.07914315 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06473409 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03582825 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03228474 |
| 110 | Base excision repair_Homo sapiens_hsa03410 | -0.2211589 |
| 111 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.2169755 |
| 112 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | -0.2098221 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | -0.1968934 |
| 114 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1934388 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1911929 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1904455 |
| 117 | Proteasome_Homo sapiens_hsa03050 | -0.1882828 |
| 118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1831614 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1648594 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1407864 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1223913 |
| 122 | Mismatch repair_Homo sapiens_hsa03430 | -0.1005241 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0912577 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0677976 |
| 125 | DNA replication_Homo sapiens_hsa03030 | -0.0614722 |

